Np.Miranda's tretinoin advice gets checked by science
Quick answer
Tretinoin cream and gel formulations differ in delivery rate and tolerability, with gel producing higher skin concentrations at equivalent labeled concentrations. The claim that isopropyl myristate in cream formulations is a primary driver of acne worsening is not supported by controlled clinical data, and vehicle choice in clinical practice is typically guided by skin type and tolerability rather than comedogenicity ratings derived from 1970s rabbit ear models. Patients experiencing persistent or worsening acne beyond eight weeks on tretinoin should consult their prescriber rather than switching formulations based on ingredient-level comedogenicity lists.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @np.miranda actually say?
The core argument here is that tretinoin cream contains isopropyl myristate, rates it a five out of five on the comedogenic scale, and concludes it will make your acne worse. The recommendation is to skip the cream entirely and go straight to gel, just at a lower concentration. That's a tidy narrative. Let's see if it holds up.
The creator also frames the "purge" as something prescribers dismiss too quickly, suggesting that when acne worsens on tretinoin, the vehicle, meaning cream versus gel, is more likely to blame than the drug itself. That's a meaningful clinical claim, and it deserves scrutiny rather than a nod.
Does the science back this up?
Partially, but the comedogenicity claim is shakier than the video implies. Isopropyl myristate does appear on several comedogenicity lists, often rated highly. But here's the problem: those ratings largely come from rabbit ear assays conducted in the 1970s and 1980s, not from controlled human skin studies. A 2018 review by Draelos in the Journal of Cosmetic Dermatology noted that comedogenicity testing methods are inconsistent and that ingredient-level ratings don't reliably predict product-level pore-clogging in humans.
The gel-versus-cream distinction is real and clinically relevant. Tretinoin gel does have higher bioavailability than the cream formulation at equivalent concentrations, which is well-documented. A 1995 study by Nyirady et al. in Cutis confirmed gel delivers more active drug per unit time. But "more delivery" also means "more irritation," which is exactly why dermatologists sometimes start patients on cream intentionally. Recommending gel universally as the safer acne option flips that logic on its head.
What did they get wrong (or right)?
Credit where it's due: the historical framing is roughly accurate. Tretinoin was originally developed as a gel by Kligman and Fulton in the late 1960s, and cream formulations did emerge partly in response to tolerability concerns. That part checks out.
What doesn't check out cleanly is the assertion that isopropyl myristate is definitively a five out of five comedogen that "is just gonna break you out." That's presented as settled fact. It isn't. The comedogenic scale the creator is referencing has real methodological baggage. Actual formulated tretinoin cream products have been used in decades of clinical trials on acne patients without isopropyl myristate being flagged as a confounding variable causing worse outcomes.
- The comedogenic ratings she cites are based on outdated animal models, not controlled human trials.
- Tretinoin cream has decades of clinical evidence supporting its use in acne, which the video doesn't acknowledge.
- The claim that cream "is just gonna break you out more" overstates what the evidence supports.
The video also doesn't mention that a worsening purge might simply be the retinoid mechanism itself, not the vehicle.
What should you actually know?
If you're starting tretinoin, the vehicle choice matters, but not in the black-and-white way this video suggests. Gel formulations are generally better suited to oily, acne-prone skin because they're lighter and less occlusive. Cream formulations are often preferred for dry or sensitive skin because the emollient base reduces irritation. Neither is universally better for acne outcomes.
The "purge" is a real phenomenon driven by tretinoin accelerating skin cell turnover and bringing comedones to the surface faster. It typically lasts four to eight weeks. A 2021 review by Zasada and Budzisz in Dermatology and Therapy confirmed this is a pharmacological effect of retinoids, not a product formulation issue.
If your acne is genuinely worsening beyond the expected purge window, that's a conversation to have with whoever prescribed it, because the answer might be concentration adjustment, frequency changes, or reassessing whether tretinoin is the right option for your skin type. Don't make that call based on a TikTok about isopropyl myristate.
Bottom line
This video raises a legitimate point about vehicle differences but oversimplifies it into a rule that could steer people away from a formulation that might actually work better for their skin type. The comedogenicity claim is based on an outdated testing model. The recommendation to universally prefer gel is not supported by current evidence and ignores tolerability trade-offs that clinicians weigh deliberately.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Np.Miranda's tretinoin advice gets checked by science, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Np.Miranda's tretinoin advice gets checked by science is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Tretinoin cream and gel formulations differ in delivery rate and tolerability, with gel producing higher skin concentrations at equivalent labeled concentrations.
FormBlends verdict
Tretinoin cream and gel formulations differ in delivery rate and tolerability, with gel producing higher skin concentrations at equivalent labeled concentrations. The claim that isopropyl myristate in cream formulations is a primary driver of acne worsening is not supported by controlled clinical data, and vehicle choice in clinical practice is typically guided by skin type and tolerability rather than comedogenicity ratings derived from 1970s rabbit ear models. Patients experiencing persistent or worsening acne beyond eight weeks on tretinoin should consult their prescriber rather than switching formulations based on ingredient-level comedogenicity lists.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Tretinoin cream and gel formulations differ in delivery rate and tolerability, with gel producing higher skin concentrations at equivalent labeled concentrations. The claim that isopropyl myristate in cream formulations is a primary driver of acne worsening is not supported by controlled clinical data, and vehicle choice in clinical practice is typically guided by skin type and tolerability rather than comedogenicity ratings derived from 1970s rabbit ear models. Patients experiencing persistent or worsening acne beyond eight weeks on tretinoin should consult their prescriber rather than switching formulations based on ingredient-level comedogenicity lists.
- Comedogenic ratings like the five-out-of-five score for isopropyl myristate come primarily from 1970s rabbit ear models, not controlled human skin trials, and don't reliably predict real-world pore-clogging in formulated products.
- Tretinoin gel does deliver more active drug per unit time than cream at equivalent concentrations, confirmed by Nyirady et al. (1995, Cutis), but that higher delivery also means higher irritation potential.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Comedogenic ratings like the five-out-of-five score for isopropyl myristate come primarily from 1970s rabbit ear models, not controlled human skin trials, and don't reliably predict real-world pore-clogging in formulated products.
- Tretinoin gel does deliver more active drug per unit time than cream at equivalent concentrations, confirmed by Nyirady et al. (1995, Cutis), but that higher delivery also means higher irritation potential.
- The tretinoin purge is a pharmacological retinoid effect driven by accelerated cell turnover, not a cream-specific problem. Zasada and Budzisz (2021, Dermatology and Therapy) document this as a class effect.
- Dermatologists often intentionally prescribe cream over gel for patients with sensitive, dry, or reactive skin because tolerability directly affects whether patients stick with the treatment.
- Acne that worsens beyond eight weeks of tretinoin use warrants a clinical conversation about concentration, frequency, or formulation, not a unilateral switch based on ingredient-level comedogenicity lists.
- Neither cream nor gel is universally better for acne. The right vehicle depends on your skin type, baseline oiliness, and how your skin tolerates the drug.
- Tretinoin cream products have decades of acne trial data behind them. Isopropyl myristate has not been identified as a clinically significant confounder in those outcomes.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Np.Miranda · TikTok creator
558.0K views on this video
If you’re thinking of starting tretinoin please watch this first! #skintip ##tretinoin##acne##acnetreatment##viral##fyp
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Np.Miranda, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.